Red blood cell aggregability is increased by aspirin and flow stress, whereas dipyridamole induces cell shape alterations: Measurements by digital image analysis

被引:6
作者
Bozzo, J [1 ]
Hernandez, MR [1 ]
delGiorgio, A [1 ]
Ordinas, A [1 ]
机构
[1] UNIV BARCELONA, SERV CIENT TECN, UNITAT TRACTAMENT IMATGE, BARCELONA, SPAIN
关键词
aspirin; blood flow; dipyridamole; echinocytes; red blood cell aggregation;
D O I
10.1046/j.1365-2362.1996.1960540.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We evaluated the influence of pretreatment with aspirin in vitro, alone or combined with dipyridamole, on red cell aggregability. Samples were tested before and after being exposed to well-defined flow conditions. An aggregation rate was estimated through digital analysis of light microscopy images. Red cells of untreated blood that had been exposed to flow showed a higher aggregation rate (38.54 +/- 1.63 vs. 27.52 +/- 1.36; P < 0.05). This effect was not observed in the absence of platelets. Treatment with aspirin induced a high aggregation rate, with or without exposure to flow conditions. Dipyridamole alone or combined with aspirin provoked echinocytosis, disturbing the rouleaux arrangement (rates ranging from 11.25 +/- 1.91 - 13.62 +/- 1.62). Washing red cells after treatment restored about 90% of echinocytes to their biconcave shape, but aggregation rate did not recover in parallel. These results highlight the influence of red cell-platelet interactions in the regulation of haemostasis and show how therapeutic agents can interfere with rheological phenomena.
引用
收藏
页码:747 / 754
页数:8
相关论文
共 46 条
[1]  
AARTS PAMM, 1983, BLOOD, V62, P214
[2]  
AARTS PAMM, 1984, BLOOD, V64, P1228
[3]   BLOOD-PLATELETS ARE CONCENTRATED NEAR THE WALL AND RED BLOOD-CELLS, IN THE CENTER IN FLOWING BLOOD [J].
AARTS, PAMM ;
VANDENBROEK, SAT ;
PRINS, GW ;
KUIKEN, GDC ;
SIXMA, JJ ;
HEETHAAR, RM .
ARTERIOSCLEROSIS, 1988, 8 (06) :819-824
[4]   DOSE-DEPENDENT ASPIRIN HYDROLYSIS AND PLATELET-AGGREGATION IN PATIENTS WITH ATHEROSCLEROSIS [J].
AKOPOV, SS ;
GRIGORIAN, GS ;
GABRIELIAN, ES .
JOURNAL OF CLINICAL PHARMACOLOGY, 1992, 32 (02) :133-135
[5]  
ALKHAMIS TM, 1990, BLOOD, V75, P1568
[6]  
BAUMGARTNER HR, 1973, MICROVASC RES, V5
[7]  
BESSIS M, 1972, NOUV REV FR HEMATOL, V12, P721
[8]   MORPHOLOGY AND VOLUME ALTERATIONS OF HUMAN ERYTHROCYTES CAUSED BY THE ANION TRANSPORTER INHIBITORS, DIDS AND P-AZIDOBENZYLPHLORIZIN [J].
BLANK, ME ;
HOEFNER, DM ;
DIEDRICH, DF .
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 1994, 1192 (02) :223-233
[9]  
BOHLER T, 1993, CLIN HEMORHEOL, V13, P775
[10]  
BOSS N, 1980, EUR J CARDIOL, V12, P47